Related Articles
Use of vonoprazan for management of systemic sclerosis‑related gastroesophageal reflux disease
Vonoprazan 10 mg daily is effective for the treatment of patients with proton pump inhibitor‑resistant gastroesophageal reflux disease
Assessment of health‑related quality of life of patients with esophageal squamous cell carcinoma following esophagectomy using EORTC quality of life questionnaires
Efficacy of a potassium‑competitive acid blocker for improving symptoms in patients with reflux esophagitis, non‑erosive reflux disease, and functional dyspepsia
Topical treatment of chronic venous ulcers with sucralfate: A placebo controlled randomized study